B&G Foods (BGS) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
3 Mar, 2026Executive summary
Completed divestiture of Green Giant U.S. Frozen business, Don Pepino, and Le Sueur U.S., with pending sales of Green Giant Canada, focusing on core shelf-stable categories.
Announced acquisition of College Inn and Kitchen Basics broth and stock businesses, expected to close by end of March/Q1 2026.
Portfolio reshaping aims to deliver higher margins, stronger cash flows, and reduced leverage.
Q4 2025 net sales declined 2.2% year-over-year to $539.6 million, mainly due to divestitures, while base business net sales rose 0.8%.
Net loss for Q4 2025 was $15.2 million, a significant improvement from a $222.4 million loss in Q4 2024, mainly due to lower impairment charges.
Financial highlights
Q4 2025 net sales: $539.6 million, down 2.2% year-over-year due to divestitures; Q4 adjusted EBITDA: $84.7 million (15.7% of net sales); adjusted net income: $22.8 million ($0.28 per share).
FY 2025 net sales: $1.829 billion; adjusted EBITDA: $272.2 million (14.9% margin); net loss: $43.3 million due to non-cash impairment charges.
Q4 2025 gross profit margin improved to 22.7% (adjusted: 23.0%) from 21.5% (adjusted: 22.2%) in Q4 2024.
Selling, general and administrative expenses increased to 10.0% of net sales in Q4 2025 and 10.7% for the year.
Net interest expense decreased 5.0% for the year due to lower debt and interest rates.
Outlook and guidance
FY 2026 net sales guidance: $1.655–$1.695 billion; adjusted EBITDA: $265–$275 million (16–16.5% margin); adjusted diluted EPS expected at $0.55–$0.65.
Guidance excludes pending Green Giant Canada divestiture and College Inn/Kitchen Basics acquisition.
Guidance reflects one fewer reporting week, recent divestitures, and does not fully reflect potential impacts of tariffs or retaliatory trade actions.
Base business trends expected to improve by 0.4% year-over-year; Q1 2026 off to a strong start with 4% growth through February.
Latest events from B&G Foods
- Q2 sales fell 5.3%, goodwill impairment hit results, and guidance was revised lower.BGS
Q2 20242 Feb 2026 - Portfolio reshaping and operational improvements target margin recovery and 2024 growth.BGS
Barclays 17th Annual Global Consumer Staples Conference22 Jan 2026 - Q3 2024 sales and EBITDA declined, but net income turned positive; outlook remains cautious.BGS
Q3 202416 Jan 2026 - Portfolio streamlining and cost initiatives aim to boost margins and enable future growth.BGS
Barclays 18th Annual Global Consumer Staples Conference 202531 Dec 2025 - Sequential improvement, strong spices growth, and major impairments shape 2025 outlook.BGS
Q4 202418 Dec 2025 - Shelf registration allows up to $800M in securities for growth, debt, and acquisitions.BGS
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG and governance.BGS
Proxy Filing1 Dec 2025 - Director elections, executive pay, and auditor ratification up for virtual shareholder vote.BGS
Proxy Filing1 Dec 2025 - Q1 2025 sales dropped 10.5% and EBITDA fell 21.2%, prompting lower guidance and cost cuts.BGS
Q1 202525 Nov 2025